José Reinaldo Chicharo de Freitas

Dr. José Reinaldo Chicharro de Freitas is a leading specialist in Nuclear Medicine , trained at the Hospital Clínico San Carlos, where he completed his specialization in 2014. He currently practices as a physician in the Nuclear Medicine department at H.QS. Málaga , making significant contributions to the field of imaging in clinical trials. His most relevant publication, "Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma," was published in the International Journal of Hematology in September 2021, highlighting its ability to predict treatment response in patients with Hodgkin lymphoma. Furthermore, Dr. Chicharro has participated in research projects such as the "COST Action: CA 19114 – Network for Optimized Astatine labeled Radiopharmaceuticals (NOAR)," reflecting his commitment to innovation in his field. His professional career is a testament to his dedication and contribution to the advancement of nuclear medicine .